Company: QTIWW
Filing Date: 2025-11-03
Form Type: S-1
Source: 0001628280-25-048373
Chunk: 381

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-11-03
Form: S-1
Chunk 381
---
 23, 2025. In connection with the Reverse Stock Split, the CUSIP number of the common stock has changed to 746962307. The common stock began trading on the QTCQB Venture Market on a reverse split-adjusted basis on October 23, 2025. The Company has submitted its application to relist on the Nasdaq Capital Market. Except as noted, all share, stock option, warrant, and per share information throughout these consolidated financial statements have been retroactively adjusted to reflect this Reverse Stock Split.

On August 21, 2025, the Company entered into the Gulf Medical Distribution Agreement with GMC. Under the terms of the Gulf Medical Distribution Agreement, the Company shall authorize and grant to GMC the exclusive right to market, advertise and sell the QT Breast Scanners and the Cloud SaaS platform subscriptions in Saudi Arabia.

On August 26, 2025, the Company and Lynrock Lake entered into the First Amendment to the Credit Agreement (“Lynrock Amended Credit Agreement”) to add an additional tranche of $ 5.0million (“Tranche B”) to the loan and increase the aggregate principal amount of the Lynrock Lake Term Loan to $ 15.1million. The proceeds of Tranche B were used to repurchase the Yorkville Warrant for an aggregate price of $ 5.0million.

On September 30, 2025, the Company entered into a Securities Purchase Agreement, by and between the Company, on the one hand, and the Purchasers, on the other hand, for the October 2025 Private Placement. At the closing of the October 2025 Private Placement on October 3, 2025, the Company issued (i) 2,232,243shares of the Company’s common stock, par value $ 0.0001per share; (ii) the Subscription Warrants with a term of five yearsfrom the initial exercise date to purchase up to an additional 4,040,272shares of common stock; and (iii) 5,424,083Pre-Funded Warrants to purchase up to an additional 1,808,055shares of common stock, exercisable any time after its issuance. The purchase price of each common share is $ 4.50and the purchase price for each Pre-Funded Warrant is $ 4.4997. Both of these amounts were paid by the Purchasers at the closing of the October 2025 Private Placement. The aggregate gross proceeds to the Company from